Jun 18, 2025 9:35 am EDT BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
Jun 13, 2025 7:45 am EDT BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
Jun 10, 2025 8:00 am EDT BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
Jun 9, 2025 7:45 am EDT BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
May 14, 2025 4:05 pm EDT BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025 9:15 am EDT Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
May 8, 2025 4:30 pm EDT BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
Apr 15, 2025 8:30 am EDT BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities